The “Rules and Regulations Pertaining to Communicable Disease Control” adopted by the Arkansas State Board of Health in 1977 pursuant to the authority conferred by Act 96 of 1913(Arkansas Statutes, 1947, Section 82-110) Section III states “The responsibility for reporting certain communicable diseases is the duty of every physician, practitioner, nurse, superintendent or manager of a dispensary, hospital, clinic, nursing or extended care home or laboratory personnel examining human specimens resulting in the diagnosis of notifiable disease or any person in attendance on a case of any disease or conditions declared notifiable.” The following document,Reportable Diseases, contains a complete list of the diseases and conditions that are reportable to the ADH.
The Meaningful Use public health option allows Eligible Hospitals (EH) to electronically submit Electronic Lab Results (ELR) using Health Language Seven (HL7) to send the data.
The NEDSS/NBS application will also use LOINC and SONMED as the vocabulary standard. Please refer to:
http://loinc.org/usage
Steps for testing an HL7 transmission:
- Prepare a test file based on the HL7 spec file
- Forward the test file to the Meaningful Use Coordinator for validation on the message structure and content
- The EH will receive a validation letter stating the results of the test
**Due to a large amount of requests, please allow a minimum of three weeks for processing your HL7 message**
If the test message does not have the correct structure or format, an e-mail will be sent to the EH with a list of the errors and suggestions (if applicable) on how to correct and resubmit the error.
Due to updates, new HL7 interfaces in production will be temporarily suspended. The ADH staff will only be validating a test message as defined by Stage I criteria for Meaningful Use only.
Once the upgrades are in place, the Arkansas Department of Health will resume activities to verify that provider interfaces with the NEDSS/NBS application are operational and in production. Production messages will resume in time for EH’s to meet Stage 2 Meaningful Use.
Contact